文献速递白血病

慢性髓性白血病无治疗缓解:患者视角与未满足需求领域

Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs.
PubMed 文献 · Leukemia · 2020-05-26

本研究调查慢性髓性白血病患者对无治疗缓解(TFR)的体验,识别未满足需求并提出改进建议。56%的患者在停药期间报告恐惧或焦虑,仅7%被询问是否需要心理支持;再启动治疗者中59%感到害怕或焦虑、56%感到抑郁,26%获得心理或情感支持;60%出现戒断症状,其中40%报告医生未充分支持症状管理。医疗专业人员应进一步考虑监测停药或再启动治疗患者的心理健康,并审查针对已识别问题的支持措施。

要点

  • 56%患者在停药期间报告恐惧或焦虑,仅7%被询问是否需要心理支持。
  • 再启动治疗者中59%感到害怕或焦虑、56%感到抑郁,26%获得心理或情感支持。
  • 60%患者出现戒断症状,其中40%报告医生未充分支持所有症状的管理。

核心结论

  • 医疗专业人员应进一步考虑如何监测停药或再启动治疗患者的心理健康,并审查针对已识别问题的支持措施。
  • 戒断症状的监测应成为停药期间的重点,同时应关注医疗专业人员如何协助管理这些症状。

研究设计与样本

  • 本研究旨在获取患者视角、识别未满足需求并提出改进建议。

主要发现

  • 56%的患者在停药期间报告恐惧或焦虑,而仅7%的患者被询问是否需要心理支持。
  • 在再启动治疗的患者中,59%感到害怕或焦虑,56%感到抑郁。
  • 26%的再启动治疗患者在此时获得心理和/或情感支持。
  • 60%的患者在停药期间出现戒断症状,然而出现戒断症状的患者中40%报告医生未充分支持所有症状的管理。

临床怎么用

  • 医疗专业人员应进一步考虑如何监测停药或再启动治疗患者的心理健康,并审查针对已识别问题的支持措施。
  • 戒断症状的监测应成为停药期间的重点,同时应关注医疗专业人员如何协助管理这些症状。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In CML, treatment-free remission (TFR) refers to having a stable deep molecular response without the need for ongoing tyrosine kinase inhibitor treatment. Whilst recommendations exist about the technical management of stopping and re-starting therapy, much is still unknown about the experiences of those considering and undertaking TFR. This study sought to obtain the patient perspective, identify areas of unmet needs and create recommendations for improvements. Fifty-six percent of patients reported fear or anxiety during treatment discontinuation, whereas only 7% of patients were asked if they needed psychological support during this period. Where patients re-initiated treatment; 59% felt scared or anxious, and 56% felt depressed. Twenty-six percent of re-initiated patients received psychological and/or emotional support at this time. Sixty percent of patients experienced withdrawal symptoms whilst discontinuing treatment, however, 40% of patients who experienced withdrawal symptoms reported that they were not fully supported by their doctor in managing all the symptoms. Healthcare professionals should further consider how they monitor the psychological well-being of patients who are discontinuing or re-initiating treatment, and review what support is offered in response to identified concerns. Surveillance of withdrawal symptoms should be a priority during treatment discontinuation, along with how healthcare professionals assist in the management of these.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Sharf G, Marin C, Bradley JA, et al. Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs. Leukemia. 2020. PMID: 32457354. doi:10.1038/s41375-020-0867-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。